Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers uncover cellular clues to vitamin A resistance in lung cancer

16.11.2005


Vitamin A deficiency has been associated with the development of lung cancer in laboratory studies. However, clinical trials of natural and synthetic derivatives of vitamin A, called retinoids, for the prevention of lung cancer have been largely unsuccessful in the general population. A new study in the November 16 issue of the Journal of the National Cancer Institute finds that targeting a previously unknown variant of a common retinoid receptor may restore the beneficial effects of retinoids in lung cancer cells.



Retinoids help regulate certain cellular functions in the body, such as cell growth and differentiation. These effects are mediated by retinoic acid receptors (RARs), including RAR-beta. Clinical trials have supported a role for the use of retinoids in the prevention of aerodigestive tract cancers. However, large randomized trials of retinoids and retinoic acid have shown that they are ineffective--and may even be harmful--in preventing lung cancer in smokers. Laboratory studies have found that, as lung cancer develops, RAR-beta becomes silenced, which makes cells resistant to retinoids. This loss of expression of RAR-beta is often seen in the lung cells of smokers.

W. Jeffrey Petty, M.D., previously of Dartmouth Medical School and now a faculty member of the Wake Forest University School of Medicine in Winston-Salem, N.C., and colleagues at Dartmouth set out to discover the mechanisms responsible for RAR-beta silencing and to see if they could restore the expression of RAR-beta using a compound called azacytidine. In the process of studying human bronchial epithelial cells that were resistant to treatment with retinoic acid, they discovered a previously unknown variant of one of the subtypes of RAR-beta.


The variant, called RAR-beta-1’, was expressed in normal lung cells and in cells sensitive to retinoic acid, but not in cells that were resistant to retinoic acid treatment or in lung cancer cells. When they treated cancer cells with azacytidine, RAR-beta-2 expression--but not RAR-beta-1’ expression--was restored, suggesting that the variant has characteristics and functions that are distinctly different from other known forms of RAR-beta and that it may play a role in retinoid resistance.

"Taken together, the data presented here directly implicate a critical role for RAR-beta-1’ in mediating retinoid biologic effects in the lung and perhaps other organ sites," the authors write. "The frequent repression of RAR-beta-1’ in lung carcinogenesis underscores its likely important biologic or clinical role. … Identification of pharmacologic approaches that restore RAR-beta-1’ expression would provide a basis for future retinoid-based combination strategies for lung cancer therapy or chemoprevention."

"The various isoforms of RAR-beta have complex relationships and interactions that appear to influence lung carcinogenesis, as illustrated by studies in mice and humans," Anita L. Sabichi, M.D., from the University of Texas M. D. Anderson Cancer Center in Houston, and colleagues write in an accompanying editorial. "The differential expression and effects of different RAR-beta isoforms are a potential area for molecular-targeted lung cancer chemoprevention, and targeting RAR-beta-1’ to overcome retinoid resistance would be one potentially promising new approach."

Kate Travis | EurekAlert!
Further information:
http://www.oxfordjournals.org

More articles from Life Sciences:

nachricht Researchers uncover protein-based “cancer signature”
05.12.2016 | Universität Basel

nachricht The Nagoya Protocol Creates Disadvantages for Many Countries when Applied to Microorganisms
05.12.2016 | Leibniz-Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NASA's AIM observes early noctilucent ice clouds over Antarctica

05.12.2016 | Earth Sciences

Shape matters when light meets atom

05.12.2016 | Physics and Astronomy

Researchers uncover protein-based “cancer signature”

05.12.2016 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>